Literature DB >> 27617133

A Case of Concurrent Miller-Dieker Syndrome (17p13.3 Deletion) and 22q11.2 Deletion Syndrome.

Paldeep S Atwal1, C Macmurdo1.   

Abstract

Features of Miller-Dieker syndrome (MDS, 17p13.3 deletion syndrome, LIS1-associated lissencephaly) include classic lissencephaly, microcephaly, cardiac malformations, growth restriction, and characteristic facial changes. Individuals with 22q11.2 deletion syndrome (DiGeorge syndrome or velocardiofacial syndrome) are known to have congenital cardiac malformations (in particular conotruncal defects), palatal abnormalities (especially velopharyngeal insufficiency), hypocalcemia, immune deficiency, learning disabilities, and characteristic facial features. This case report describes phenotypic characteristics of a patient with extremely rare instance of having both MDS and 22q11.2 deletion syndrome that is unique in the medical literature. Prognosis in this concurrent phenotype is poor with our patient suffering from several malformations seen in both conditions and expiring in the neonatal period.

Entities:  

Keywords:  17p13.3 deletion; 22q11.2 deletion syndrome; Miller-Dieker syndrome

Year:  2015        PMID: 27617133      PMCID: PMC4906526          DOI: 10.1055/s-0035-1565267

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  8 in total

1.  Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.

Authors:  Damien L Bruno; Britt-Marie Anderlid; Anna Lindstrand; Conny van Ravenswaaij-Arts; Devika Ganesamoorthy; Johanna Lundin; Christa Lese Martin; Jessica Douglas; Catherine Nowak; Margaret P Adam; R Frank Kooy; Nathalie Van der Aa; Edwin Reyniers; Geert Vandeweyer; Irene Stolte-Dijkstra; Trijnie Dijkhuizen; Alison Yeung; Martin Delatycki; Birgit Borgström; Lena Thelin; Carlos Cardoso; Bregje van Bon; Rolph Pfundt; Bert B A de Vries; Anders Wallin; David J Amor; Paul A James; Howard R Slater; Jacqueline Schoumans
Journal:  J Med Genet       Date:  2010-05       Impact factor: 6.318

2.  Practical guidelines for managing patients with 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Donna M McDonald-McGinn; Koen Devriendt; Maria Cristina Digilio; Paula Goldenberg; Alex Habel; Bruno Marino; Solveig Oskarsdottir; Nicole Philip; Kathleen Sullivan; Ann Swillen; Jacob Vorstman
Journal:  J Pediatr       Date:  2011-05-12       Impact factor: 4.406

3.  Further delineation of the 17p13.3 microdeletion involving YWHAE but distal to PAFAH1B1: four additional patients.

Authors:  Manuel Schiff; Andrée Delahaye; Joris Andrieux; Damien Sanlaville; Catherine Vincent-Delorme; Azzedine Aboura; Brigitte Benzacken; Sonia Bouquillon; Monique Elmaleh-Berges; Audrey Labalme; Sandrine Passemard; Laurence Perrin; Sylvie Manouvrier-Hanu; Patrick Edery; Alain Verloes; Séverine Drunat
Journal:  Eur J Med Genet       Date:  2010-07-03       Impact factor: 2.708

Review 4.  Chromosome 17p13.3 deletion syndrome: aCGH characterization, prenatal findings and diagnosis, and literature review.

Authors:  Chih-Ping Chen; Tung-Yao Chang; Wan-Yuo Guo; Pei-Chen Wu; Liang-Kai Wang; Schu-Rern Chern; Peih-Shan Wu; Jun-Wei Su; Yu-Ting Chen; Li-Feng Chen; Wayseen Wang
Journal:  Gene       Date:  2013-09-19       Impact factor: 3.688

5.  Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatment.

Authors:  John R Østergaard; Jesper Graakjær; Carsten Brandt; Niels H Birkebæk
Journal:  Eur J Med Genet       Date:  2011-10-24       Impact factor: 2.708

Review 6.  22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development.

Authors:  Peter J Scambler
Journal:  Pediatr Cardiol       Date:  2010-04       Impact factor: 1.655

Review 7.  Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.

Authors:  Sarah E Prasad; Sarah Howley; Kieran C Murphy
Journal:  Dev Disabil Res Rev       Date:  2008

8.  Combination of Miller-Dieker syndrome and VACTERL association causes extremely severe clinical presentation.

Authors:  Hiroko Ueda; Tokio Sugiura; Satoru Takeshita; Koichi Ito; Hiroki Kakita; Rika Nagasaki; Kenji Kurosawa; Shinji Saitoh
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.